GALR1 and colorectal carcinoma: We found that GalR1 and GAlR2 relative immunoreactivity (comparing CRC cells vs. normal epithelial cells) did not correlate with the overall survival and clinical-pathological data of CRC patients (Figure 5A and Figure 5B, respectively).